MLi-2 T16115
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
MLi-2 is a structurally novel, highly potent, and selective LRRK2 kinase inhibitor with central nervous system activity.�MLi-2 exhibits exceptional potency in a purified LRRK2 kinase assay in vitro (IC50 = 0.76 nM), a cellular assay monitoring dephosphory
CAS nr:
1627091-47-7
Purity:
98%
Molecular Weight:
379,46
SMILES:
C[C@@](C1)([H])O[C@](C)([H])CN1C2=CC(C3=NNC4=CC=C(OC5(C)CC5)C=C43)=NC=N2
Formula:
C21H25N5O2
Pathway:
Autophagy
Target:
LRRK2
